{
  "ticker": "ABT",
  "company": "Abbott Laboratories",
  "quarter": "Q3 2025",
  "date": "2025-07-28",
  "content": "Abbott Laboratories Financial Overview\nData as of: 2025-07-28\n\nCompany Metrics:\nStock Price: $191.83\nMarket Cap: $450,851,267,416\n52-Week High: $249.38\n52-Week Low: $134.28\n\nValuation Metrics:\nP/E Ratio (TTM): 25.0\nForward P/E: 22.5\nPEG Ratio: 2.51\nPrice to Book: 8.6\n\nFinancial Performance:\nRevenue (TTM): $72,883,533,557\nRevenue Growth (YoY): 49.0%\nGross Margin: 67.9%\nOperating Margin: 9.6%\nNet Margin: 7.7%\n\nProfitability:\nReturn on Assets: 10.2%\nReturn on Equity: 25.8%\nProfit Margin: 7.7%\n\nTrading Information:\nBeta: 0.94\nDividend Yield: 4.57%\nPrevious Close: $188.00\nDay Range: $186.08 - $195.67\nVolume: 32,971,996\nAverage Volume: 47,023,445",
  "source": "batch-cache",
  "cached_at": "2025-07-28T21:15:02.666938"
}